Eli Lilly and Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (53)

Latest Posts

About This Stock More About This Stock
Healthcare (Top 30 Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes
Monday, February 17, 2020 5:44 AM EST
The cumulative 2020 earnings power of these 30 stocks was revised down by -.34% in the past 60 days.
In this article: EW, HCA, HUM, JNJ, LLY, MDT, MRK, PFE, SYK, TMO, UNH, ILMN, AMGN, BIIB, GILD, ISRG, VRTX Also: ABT, AGN, BAX, BDX, BMY, BSX, CI, CNC, CVS, DHR, XLV, ZTS, ABBV, ANTM
Read
Week In Review: Four China Biopharmas Announce $100+ Million Deals In First Week Of 2020
Article By: ChinaBio® Today
Saturday, January 11, 2020 4:11 PM EST
Apollomics of Hangzhou announced a $189 million agreement to develop two GlycoMimetics novel E-selectin-based immunotherapies in China for leukemia. Apollomics will be responsible for developing uproleselan and GMI-1687.
In this article: LLY, GLYC, BPMC, ZLAB
Read
E Boris Bounce; Trump Tripwire
Article By: Vivian Lewis
Sunday, December 15, 2019 5:30 PM EST
Boris Johnson beat the pollsters handily and Britain went into holiday mode. Meanwhile back on Capitol Hill, the on-again-off-again trade deal with China was on again on. The drug price limits bill is dead in the water which will boost pharma stocks.
In this article: BLRX, LLY, RHHBY, EXEL, GSK, BVNRY, CZZ, IRL, MXE, NOK, SLB, MXCHF, NPSNY, TCEHY, HOLI, AQN, PROSY
Read
Week In Review: BeiGene Forms Blockbuster $2.7 Billion Collaboration With Amgen
Article By: ChinaBio® Today
Sunday, November 3, 2019 1:34 AM EST
BeiGene, a Beijing cancer biopharma, announced a blockbuster collaboration with Amgen. I-Mab, a Shanghai biopharma, has filed to IPO; Aesthetic Medical International Holdings, a Shenzhen aesthetics company, completed a $30 million IPO on NASDAQ.
In this article: LLY, AMGN, BGNE, AIH, SNCA
Read
3 Big Drug/Biotech Stocks Set To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Saturday, October 12, 2019 10:00 AM EST
Overall, relatively newer drugs have been driving the top line of most of the big shots backed by higher demand - a trend we expect to have benefited third-quarter sales.
In this article: LLY, ALXN, AMGN Also: JNJ
Read

PARTNER HEADLINES

Latest Tweets for $LLY

No tweets yet!

$LLY

Stocks For You To Swing-Trade: LLY CMA TTWO
Alpha Stockman 11/12/2018 8:21:19 AM

These look like some good picks. Liking $CMA, $LLY, $TTWO

1 to 1 of 1 comments